By Yasmin Gagne December 03, 2023 As drugs like Ozempic and Wegovy become more widespread, an increasing number of employees are asking their insurance to cover them. Recently though, employers including the University of Texas and private healthcare system Ascension have halted coverage saying that they cannot keep up with the rising costs as … Continue reading This $2 billion unicorn startup is corporate America’s secret weapon against Ozempic
By Yasmin Gagne November 05, 2023 After John Furner, president and CEO of Walmart U.S., told Bloomberg in October that GLP-1s, a class of medications prescribed for weight loss—which include Ozempic, Mounjaro, and Wegovy—are changing how shoppers behave, resulting in their buying slightly less food, shares for Mondelez (maker of Oreo), PepsiCo, and Hershey’s … Continue reading Ozempic is not going to slim down your stock portfolio (yet)
By Yasmin Gagne July 03, 2023 As Elon Musk and Mark Zuckerberg continue to train for the fight no one asked for, new pictures of Musk taking podcast host Lex Fridman down on the mat in a sparring match have emerged—and he’s looking rather trim. This might be because of his continued use of … Continue reading Your employer could soon be footing your Ozempic bill
By Yasmin Gagne March 18, 2023 You’re not hallucinating. Ozempic is everywhere. The diabetes medication, which can also be used for long-term weight management, has become a near-overnight sensation, moving from hushed Hollywood diet aid to the mainstream. Ozempic is now on the cover of magazines, the lips of comedians, and in TV … Continue reading Ads for weight-loss drug Ozempic are now blanketing New York City subways
